National example: Italian Medicines' Agency

L. Pani (Rome, Italy)

Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Number: 6

PDF journal article, handout or slidesSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Pani (Rome, Italy). National example: Italian Medicines' Agency. Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The ERS Research Agency: the beginning
Source: Eur Respir J 2016; 47: 1017-1023
Year: 2016


How to assist bringing new drugs to patients: role of the European Medicines Agency
Source: International Congress 2019 – Rare lung diseases
Year: 2019


WHO Collaborating Research Centre for Children‘s Environmental Health: collaborative research strategies
Source: Eur Respir J 2005; 26: Suppl. 49, 449s
Year: 2005

A national example: German Centre for Lung Research
Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Year: 2014


European Asthma Research and Innovation Partnership (EARIP)
Source: Research Seminar 2013 - Translational animal models of asthma
Year: 2013


Update of the British Occupational Health Research Foundation (BOHRF) guidelines on occupational asthma.
Source: International Congress 2018 – Occupational and environmental lung diseases: from early influences and novel exposures to preventative approaches
Year: 2018



European Union Standards for Tuberculosis Care
Source: Eur Respir J 2012; 39: 807-819
Year: 2012



World Health Organization Collaborating Centre for Research and Training in Management of MDR-TB – curricula and methods
Source: Eur Respir J 2005; 26: Suppl. 49, 191s
Year: 2005

The Finnish Allergy Programme 2008–2018 works
Source: Eur Respir J, 49 (6) 1700470; 10.1183/13993003.00470-2017
Year: 2017



Innovative Medicines Initiatives (IMI)
Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Year: 2014


Medicines for Children - the UK experience
Source: Research Seminar 2006 - Preventing respiratory sequelae in children diagnosed with cystic fibrosis by newborn screening
Year: 2006


Reducing tuberculosis transmission: a consensus document from the World Health Organization Regional Office for Europe
Source: Eur Respir J, 53 (6) 1900391; 10.1183/13993003.00391-2019
Year: 2019



ERS International Congress 2020: highlights from the Epidemiology and Environment Assembly
Source: ERJ Open Res, 7 (1) 00849-2020; 10.1183/23120541.00849-2020
Year: 2021



ERS International Congress, Madrid, 2019: highlights from the Epidemiology and Environment Assembly
Source: ERJ Open Res, 6 (1) 00320-2019; 10.1183/23120541.00320-2019
Year: 2020



The National Asthma and COPD Audit Programme in East Kent Hospitals University NHS Foundation Trust – The first year
Source: International Congress 2019 – Nursing care across the spectrum of respiratory illnesses
Year: 2019

Supervision/monitoring system under the National TB Control Program in Romania
Source: Eur Respir J 2005; 26: Suppl. 49, 190s
Year: 2005

Romanian strategy for the reorganization of the National Tuberculosis Laboratory Network according to the WHO recommendations
Source: Eur Respir J 2006; 28: Suppl. 50, 17s
Year: 2006

Collaboration between the Russian National CF Patient Registry and the European CF Society Patient Registry
Source: International Congress 2018 – Russian Speaking Programme 2018: Part I
Year: 2018